Other

Neuland Laboratories Limited

Neuland Pharma Research Private Limited

Davuluri Ramamohan Rao

Rao, Davuluri Ramamohan

Ponnaiah Ravi

Praveen Kumar Neela

Batthini Guruswamy

Praveenkumar Neela

Guruswamy Batthini

Neela Praveen Kumar

Naresh Dongari

Dongari Naresh

Mailapalli Dhanunjaya

Sribhashyam Ravikanth

Narayana Venugopala Rao

Vishal Rajput

Krishnaiah Pendem

Narayana Venugopalarao

Somepalli Prasad

Bondada Anilkumar

Bathini Guruswamy

Uppala Manikya Rao

Satya Nagendra Kumar Lakkadasu

Kashyap Ravindrabhai Wadekar

Kubireddy Vigneshwar Reddy

Mahesh Gattikoppula

Sampath Kumar Laxmalla

The present invention relates to an improved process for the preparation of Aripiprazole Lauroxil of Formula (I). 

Process for the preparation of aripiprazole lauroxil

The present invention provides a process for the preparation of sugammadex sodium involving the step of: reacting 6-perdeoxy-6-per-halo-gamma-cyclodextrin with 3-mercapto propionic acid in the presence of alkali metal alkoxide in an organic solvents. The invention also provides a process for purifying the sugammadex or its pharmaceutically acceptable salts using water and organic solvents.

Process for preparation of sugammadex sodium

A novel process the for preparation of Indacaterol or its pharmaceutically acceptable salts and novel intermediates employed in the preparation thereof that is economically significant for large scale.

Process for preparation of indacaterol or its pharmaceutically acceptable salts

An improved process for preparation of Olanzapine pamoate monohydrate from Olanzpaine is disclosed which comprises mixing at room temperature a solution of olanzapine prepared in water in presence of an acid, with a solution of pamoic acid prepared in water in presence of a base; stirring and maintaining the reaction mixture for a sufficient time till precipitation of solid and drying the solid to obtain olazapine pamoate monohydrate.

Process for the preparation of olanzapine pamoate

An improved, cost effective process for the preparation of Lacosamide is disclosed. A novel intermediate of formula (IV) and a process for preparation of the novel intermediate is also disclosed. wherein, X is halogen.

Process for the preparation of lacosamide and its novel intermediate

A process for the purification of Bosentan sodium and a novel crystalline form of substantially pure Bosentan sodium to disclosed in this invention.

4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2(2-pyrimidinyl)-pyrimidine-4-yl)-benzen esulfonamide sodium

Growing community of inventors

Madurai, India

Ponnaiah Ravi